Sick Dividends. Big Pharma, High Dividend Stocks, High Growth Stocks, REITs, Closed End Funds & more.
SickDividends.com is a sister site of SickEconomics.com
SICK PICKS
Our favorite dividend shares in today’s stock market. Highlighting companies that stand to profit through innovation, mismatches in share price to market potential, or just plain great economics.
(Stocks may be owned by the Sick Economist, or other commentators on this page.)
DOW
Dow Chemical makes the stuff that makes the modern world function. It’s likely that you come into contact with Dow’s products each and every day, even if you don’t realize it. Dow manufactures thousands of basic chemicals used in dozens of different industries around the world. Over the decades, Dow has proven to offer a very resilient business model, with high and growing dividends.
Click On Chart To Expand
IRM
Iron Mountain stores paperwork and data for 95% of the Fortune 1000 companies. If information is the lifeblood of commerce, then IRM is essential to the continued survival of Global Business. The company’s legacy business (paper records storage) provides steady and recurring revenue, while the company’s growth businesses (digital storage and services) create the growth that investors need for the 21st century. Structured as a REIT, Iron Mountain constantly puts that growing cash flow right back into investors’ pockets.
Click On Chart To Expand
NVO
Novo Nordisk is one of the world’s premier providers of novel medicines for diabetic&obese patients. With diabetes expected to afflict 750 million people by 2045, Novo is a pure growth play. Lately, the company has launched a new product, Wegovy, that is the first medicine scientifically proven highly efficacious against obesity. This should open a brand new market for Novo, with the potential to eventually sell the medicine to billions of people world wide. Although Novo’s dividend is modest today, the company’s potential for explosive growth could mean a cash flow bonanza for shareholders.
Click On Chart To Expand
DIVIDEND GROWTH STOCKS
These stocks don’t always offer the highest dividend payout today, but they offer the strongest growth over time. These are a collection of healthy, rapidly growing businesses that will aim to increase their dividends year after year, decade after decade. These stocks will keep working for you, long after you have retired.
ABBOTT LABS: REAPING THE DIVIDENDS OF AN AGING PLANET
By Herbert Han Cook Introduction In the healthcare sector, Abbott Laboratories stands as…
ALPHABET, INC: A DIVIDEND STAR IS BORN?
Hell has officially frozen over. Alphabet Inc (AKA, Google) has finally declared a dividend….
MCDONALD’S: SERVING UP TASTY DIVIDEND PROSPECTS
By Jose P Lopez McDonald’s Corporation, a renowned leader in the fast-food industry, stands…
HIGH DIVIDEND STOCKS
These stocks pay high dividends today to maximize your current passive income. They can create a monthly or quarterly paycheck for you. They offer high income with low work on your part.
TOTAL ENERGIES: PREPARED FOR THE UNKNOWN
Donald Rumsfeld, who held just about every major Federal Government cabinet post over a…
VERIZON COMMUNICATIONS INC: DIALING UP A HIGH DIVIDEND
By Jose P. Lopez Introduction….A Secure Connection? Verizon Communications stands as one of…
HOW SAFE IS ABBVIE’S DIVIDEND?
By Mackenzie Deming, Equity Analyst Let’s talk about Abbvie– this company was derived…
THE BASICS OF INVESTING WITH RYAN JAMES
Junior equity analyst Ryan James seeks to empower the average investor through education. Ryan strives to explain the fundamentals of investing in simple language that anyone can understand. In these posts Ryan shares specific knowledge that will help you start down the road of financial independence.
APPLE: A FUTURE AI POWERHOUSE?
By Ryan James, Dividend Analyst Fellow Big Tech’s Dominance The so-called “Magnificent Seven” stocks—Apple…
WHICH SEMICONDUCTOR STOCK WILL END UP ON TOP?
By Ryan James, Dividend Analyst Fellow Market Ferver Currently, despite ongoing recession fears, large…
3M: IS THIS DIVIDEND KING LANGUISHING?
By Ryan James, Dividend Analyst Fellow Company History Founded in 1902, the multinational…
BIG PHARMA DIVIDENDS
Good for what ailes you. Many of these companies have been in business for a century or more, grinding out dependable and growing dividends over the decades. The perfect Rx for passive income.
J&J: THE NEXT ELI LILLY?
By the Sick Economist This wasn’t supposed to happen. It really shouldn’t be….
PFIZER, INC: A MISUNDERSTOOD STOCK?
By Mackenzie Deming, Equity Analyst The Pfizer public perception versus reality: let’s talk…
ELI LILLY GOES BEAST MODE!
Over the past year, staid, reliable, corporate stalwart Eli Lilly has unleashed a massive attack…
DIVIDEND REITs
These are special corporations with special rules, that focus exclusivly on real estate. From strip centers to single family homes to senior living, you can own it all with the click of a button. You can earn real passive income from real estate.
THREE REITS DELIVERING SAFETY IN AN UNCERTAIN WORLD
By the Sick Economist REITs have been a very popular income investment over…
HIGH YIELD HEALTHCARE: AN INTERVIEW WITH JUSSI ASKOLA
Jussi Askola is the President of Leonberg Capital, a boutique investment research firm specializing in…
CLOSED END FUNDS
These are funds built just to maximize regular cash distributions. Many offer higher regular income that other kids of dividend paying securities. Open your eyes to cash flow opportunities with closed end funds.
NEW MOUNTAIN FINANCIAL: SOLID HIGH INCOME
By The Sick Economist Regarding financial crises, investing legend Warren Buffett once quipped,…
CLOSED END FUNDS: SPECIAL VEHICLES FOR SPECIAL INCOME
By the Sick Economist You really can visualize a Closed End Fund as a…
THE DIVIDEND EXPLAINER
How can you make your money work hard for you? It’s not black magic that only works for Manhattan Socialites. With self directed study and determination, anyone can learn to achieve passive income, so that they are the master of their money, rather than the other way around.
MASTERING THE PROXY STATEMENT PART IV: PAY FOR PERFORMANCE…?
In part III of this series, we explained how you can find out who really…
MASTERING THE PROXY STATEMENT, PART III: Q&A
By The Sick Economist In parts I and II, we explored the meaning…
MASTERING THE PROXY STATEMENT, PART II: CLARITY
In part I of this six part series, we defined the problem that many investors…